Skip to main content
Cellbion Co., Ltd logo

Cellbion Co., Ltd — Investor Relations & Filings

Ticker · 308430 ISIN · KR7308430008 KO Manufacturing
Open in API
Filings indexed 56 across all filing types
Latest filing 2026-05-15 Director's Dealing
Country KR South Korea
Listing KO 308430

About Cellbion Co., Ltd

http://www.cellbion.co.kr

Cellbion Co., Ltd. is a company engaged in the research, development, and commercialization of radiopharmaceuticals. It specializes in Radioligand Therapy (RLT), developing both therapeutic and diagnostic agents to address unmet medical needs, primarily in oncology. The company's pipeline features innovative treatments, including antibody-based approaches and radioactive probes for medical imaging. A key therapeutic candidate in its portfolio is Lu-177-DGUL. Cellbion's focus is on advancing the field of nuclear medicine through novel drug development.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 93% confidence The document is a statutory "임원ㆍ주요주주 특정증권등 소유상황보고서" (Report on Holdings of Certain Securities by an Officer/Major Shareholder) filed with the securities regulator and exchange. It details shareholdings, changes in stock ownership, exercise of stock options, and percentages before and after the transaction. This matches the definition of Director’s Dealing (Code: DIRS) – a report of personal share transactions by company directors/executives.
2026-05-15 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 95% confidence The document is a Korean “분기보고서 (Quarterly Report)” for the period 2026-01-01 to 2026-03-31 (제17기 1분기). It is filed with the Financial Services Commission and the Korea Exchange and contains comprehensive financial statements, capital changes, share information, business overview, company history, and pipeline details. This matches the definition of an Interim/Quarterly Report rather than just an announcement or summary. Therefore, it should be classified as an Interim/Quarterly Report (IR). Q1 2026
2026-05-14 Korean
증권발행결과(자율공시) (제3회차 CB)
Capital/Financing Update Classification · 90% confidence The document is a voluntary disclosure titled “증권 발행결과(자율공시)” describing the issuance results of the 3rd series convertible bonds, including issuance amount, dates, methods, and related details. It clearly pertains to the company’s financing activity (fundraising via bond issuance). This aligns with Capital/Financing Update (CAP).
2026-04-23 Korean
증권발행결과(자율공시) (제3자배정-전환우선주)
Share Issue/Capital Change Classification · 88% confidence The document is a voluntary disclosure (‘자율공시’) titled “증권 발행결과” detailing the issuance results of convertible preferred shares through a third-party allotment, including number of shares, amounts, board resolution and payment dates. This is an announcement of a share issue/capital change, matching the “Share Issue/Capital Change” category.
2026-04-23 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 87% confidence The document is a detailed ‘주요사항보고서’ (Material Event Report) concerning the decision to issue convertible bonds, including full terms, amounts, conversion mechanics, options, and investor breakdowns. This constitutes a financing activity describing a new debt issuance (with conversion features) for raising capital. It is not merely an announcement of report publication, nor a management change, legal notice, or earnings release. It fits squarely into the “Capital/Financing Update” category.
2026-04-22 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 82% confidence The document is a detailed ‘주요사항보고서’ (Major Event Report) concerning a decision for a paid-in capital increase via third‐party allocation and includes corrections to the originally filed report. It is not a short notice or link announcement but the full regulatory filing detailing share issuance terms. According to the classification definitions, this corresponds to a Share Issue/Capital Change announcement (Code: SHA).
2026-04-22 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.